Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,144 shares at $149.21 ($1.1M) on 2018-02-12, disclosed to the SEC on 2018-02-14.
Seasonal sale ($1.1M) by EVP GMDA, CMO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.21 | 1,300 | $194K | 18.0% |
| 2 | $150.47 | 1,100 | $166K | 15.3% |
| 3 | $151.26 | 2,022 | $306K | 28.4% |
| 4 | $151.26 | 2,022 | $306K | 28.4% |
| 5 | $152.62 | 400 | $61K | 5.7% |
| 6 | $153.69 | 300 |
| $46K |
| 4.3% |
| Total | $150.94 avg | 7,144 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2018-01-03 | $756K | — | Filing → |
| VRTX | SELL | 2017-11-06 | $1.5M | — | Filing → |